Keyphrases
APOBEC3A
100%
APOBEC3
65%
Replication Stress
39%
Chromosome 5
37%
Structural Maintenance of Chromosomes
37%
Genotoxicity
37%
Hematological Malignancies
37%
Malignancy
33%
DNA Damage Response
32%
Mutagenesis
31%
Cytidine Deaminase
30%
In Cancer
28%
Pediatric Patients
23%
DNA Damage Signaling
22%
Human Cancer
20%
Deamination
18%
DNA Damage
18%
Genomic Instability
18%
DNA Breaks
17%
Infections in children
16%
Double-strand Breaks
16%
Cytosine Deaminase
15%
DNA Replication
15%
Immunocompromised Pediatric Patients
15%
Neurofibromatosis Type 1 (NF-1)
15%
Neurofibromatosis Type I
15%
B Cells
15%
Children with Cancer
14%
Infection Risk
14%
Viral Infection
14%
Cancer Therapy
14%
DNA Damage Checkpoint
14%
Physiologic
14%
Acute Myeloid Leukemia
13%
Therapeutic Vulnerabilities
13%
Pediatric Cancer
12%
Antineoplastic Drugs
12%
Aging
12%
Vascular Anomalies
12%
Sirolimus
12%
Etiology
12%
Base Editor
12%
Allogeneic Hematopoietic Cell
12%
Anti-HBc
12%
Pediatric Cancer Patients
12%
Curvularia
12%
Chaperonin
12%
TCP1
12%
Fungal Sequencing
12%
Adenovirus Disease
12%
Medicine and Dentistry
Malignant Neoplasm
48%
Infection
40%
Hematologic Malignancy
37%
Cancer
34%
Pediatrics Patient
34%
Diseases
21%
Pediatric Cancer
20%
DNA Damage Response
18%
Neoplasm
15%
Neurofibromatosis Type I
15%
Pediatrics
12%
Vascular Anomaly
12%
Glycosylation
12%
Systematic Review
12%
Chimeric Antigen Receptor T-Cell
12%
Sickle-Cell Disease
12%
Hepatitis B Core Antibody
12%
Rapamycin
12%
Infarction
12%
Osteomyelitis
12%
Human Adenovirus Infection
12%
Fungal Infection
12%
Magnetic Resonance Imaging
12%
Infectious Complication
12%
Cytosine Deaminase
12%
Immunoassay
12%
Stem Cell Transplant
12%
Antivirus Agent
12%
Mycosis
12%
Clinical Study
12%
Mutagenesis
12%
Cancer Cell
12%
Polyethylene Terephthalate
12%
Chronic Myelogenous Leukemia
12%
Peptidase
9%
Signal Peptide
9%
Juvenile Myelomonocytic Leukemia
9%
Immunoglobulin
8%
Leukemia
8%
Gene Rearrangement
8%
Genomic Instability
8%
Positron Emission Tomography
7%
Drive
7%
Acute Myeloid Leukemia
7%
Acute Lymphoblastic Leukemia
7%
Human Adenovirus C
6%
Saturated Fatty Acid
6%
B Cell
6%
Mutagenic Activity
6%
Pneumocystis Jirovecii
6%
Biochemistry, Genetics and Molecular Biology
Enzyme
45%
Chromosome 5
37%
DNA Damage Response
36%
DNA Synthesis
35%
Deamination
35%
Mutagenesis
34%
Cytidine Deaminase
34%
Cytosine Deaminase
33%
Genome Instability
25%
DNA Damage
24%
Cancer Cell
19%
Cytidine
16%
RAG1
12%
Genome Editing
12%
Quantitative Technique
12%
Small Molecule
12%
Curvularia
12%
Carcinogenesis
12%
B Cell
12%
Cytotoxicity
12%
Nuclease
12%
Chaperonin
12%
Immunity
12%
Anticancer
12%
Nucleic Acid Base Substitution
10%
APOBEC
10%
Single-Stranded DNA
10%
Cell Cycle Arrest
8%
Innate Immunity
8%
Cell Cycle Checkpoint
8%
Gene Rearrangement
8%
Kinase
7%
Phosphotransferase
7%
DNA Damage Checkpoint
6%
Solution and Solubility
6%
Mutagenic Activity
6%
Cell Death
6%
Mould
6%
Cell Damage
6%
Programmed Cell Death
6%
Somatic Mutation
5%
Intravenous Immunoglobulin
5%
Cell Viability
5%